76162-142-01 : NDC 2026 Code

76162-142-01 : Acetaminophen, Aspirin, Caffeine ( Topcare Extra Strength Headache Relief )

Additionally :

You can get information about “76162-142-01” NDC code in 76162-142-01 in HTML format

HTML | 76162-142-01 in TXT (Plain Text) format

TXT | 76162-142-01 in PDF (Portable Document Format)

PDF | 76162-142-01 in XML format

XML formats.

NDC Code : 76162-142-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "76162-142-01",
    "PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (76162-142-01)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
    "NDC11Code": "76162-0142-01",
    "ProductNDC": "76162-142",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Topcare Extra Strength Headache Relief",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Aspirin, Caffeine",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20231109",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "505G(a)(3)",
    "LabelerName": "Topco Associates LLC",
    "SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE",
    "StrengthNumber": "250; 250; 65",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-12-04",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20231109",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}